Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Alzheimers Dement. 2020 Jan;16(1):209–218. doi: 10.1002/alz.12009

Table 3.

Contributions to variance in the rate of global cognitive decline from demographics, neuropathologic indices, and brain volumetric measures

Variables Model Identifiers
Ref 1 2 3
Time −0.100 (0.004)e −0.108 (0.005)e 0.002 (0.009) −0.018 (0.009)a
Age 0.001 (0.001) 0.002 (0.001)d 0.003 (0.001)e
Sex 0.024 (0.010)b 0.009 (0.008) −0.006 (0.008)
Education 0.003 (0.001)c 0.002 (0.001)b 0.002 (0.001)b
AD Pathology −0.068 (0.006)e −0.058 (0.006)e
Gross Infarcts −0.029 (0.008)d −0.027 (0.008)d
Lewy Bodies −0.026 (0.009)c −0.025 (0.008)c
Hippocampal Sclerosis −0.058 (0.012)e −0.040 (0.012)d
TDP-43 −0.009 (0.004)c −0.006 (0.004)a
Arteriolosclerosis −0.019 (0.005)e −0.015 (0.005)d
Hippocampal Volume 0.061 (0.010)e
% of Variance Accounted for by All Effects - 3.4% 42.6% 48.0%
% of Variance Accounted for by Effects in Boldface Only - 3.4% 39.2% 5.4%
Model for Comparison - Ref 1 2
a

p < 0.1,

b

p < 0.05,

c

p < 0.01,

d

p < 0.001,

e

p < 0.0001